Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Unvaccinated adult cancer patients with COVID seven times more likely to die from any cause than comparable patients without COVID infection
Unvaccinated adult cancer patients with COVID were found to be seven times more likely to…
Report reveals experiences of outpatient cancer care during COVID-19 pandemic
A report released today by the Bureau of Health Information (BHI) provides new insights into…
Targeting Cancer Fun Run returns to call for closing the care gap
The Royal Australian and New Zealand College of Radiologists (RANZCR) is pleased to announce the…
Neuroendocrine tumours: choosing the best treatment
An increasing number of new anti-cancer drugs are made available each year. During the authorisation process, such new drugs usually…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.